We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSMT icon
3001
Pricesmart
PSMT
$5.33B
$222K ﹤0.01%
2,816
-9,393
-77% -$693K
KIDS icon
3002
OrthoPediatrics
KIDS
$633M
$221K ﹤0.01%
4,093
-639
-14% -$32.6K
IMVT icon
3003
Immunovant
IMVT
$8.45B
$220K ﹤0.01%
39,932
-28,012
-41% -$174K
TSHA icon
3004
Taysha Gene Therapies
TSHA
$1.92B
$220K ﹤0.01%
33,694
+14,059
+72% +$105K
MITT
3005
TPG Mortgage Investment Trust
MITT
$214M
$219K ﹤0.01%
23,556
-9,823
-29% -$94.5K
MLAB icon
3006
Mesa Laboratories
MLAB
$622M
$219K ﹤0.01%
+858
New +$233K
SYK icon
3007
Stryker
SYK
$134B
$219K ﹤0.01%
821
-16,596
-95% -$4.29M
WHWK
3008
Whitehawk Therapeutics
WHWK
$266M
$218K ﹤0.01%
12,826
+1,851
+17% +$35.5K
RGTI icon
3009
Rigetti Computing
RGTI
$6.04B
$217K ﹤0.01%
+34,428
New +$306K
CBSH icon
3010
Commerce Bancshares
CBSH
$8.47B
$216K ﹤0.01%
3,673
-36,580
-91% -$2.14M
MODV
3011
DELISTED
ModivCare
MODV
$216K ﹤0.01%
+1,870
New +$216K
HORI
3012
DELISTED
Emerging Markets Horizon Corp. Class A Ordinary Shares
HORI
$216K ﹤0.01%
+21,888
New +$216K
AGEN
3013
Agenus
AGEN
$307M
$215K ﹤0.01%
+4,461
New +$241K
KZR
3014
DELISTED
Kezar Life Sciences
KZR
$215K ﹤0.01%
1,294
+34
+3% +$4.88K
AD
3015
Array Digital Infrastructure
AD
$3.01B
$215K ﹤0.01%
+7,128
New +$215K
FTEV.U
3016
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$215K ﹤0.01%
21,807
-297
-1% -$2.93K
ATRS
3017
DELISTED
Antares Pharma, Inc.
ATRS
$215K ﹤0.01%
52,383
+41,054
+362% +$149K
LCAA
3018
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$213K ﹤0.01%
21,861
– –
PGNY icon
3019
Progyny
PGNY
$2.04B
$212K ﹤0.01%
+4,129
New +$177K
SLAI
3020
DELISTED
SOLAI Ltd ADS
SLAI
$211K ﹤0.01%
1,083
+248
+30% +$58.3K
WAVC.U
3021
DELISTED
Waverley Capital Acquisition Corp. 1 Units, each consisting of one Class A Ordinary Share and one-third of one redeemable warrant
WAVC.U
$211K ﹤0.01%
+21,502
New +$212K
GPMT
3022
Granite Point Mortgage Trust
GPMT
$60.2M
$210K ﹤0.01%
18,896
-30,813
-62% -$353K
LCW
3023
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
$209K ﹤0.01%
+21,214
New +$208K
ARCE
3024
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$209K ﹤0.01%
9,886
-22,682
-70% -$443K
BZ icon
3025
Kanzhun
BZ
$7.49B
$208K ﹤0.01%
8,363
-10,055
-55% -$293K
119 120
121
122 123

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.